Detailed Organ System Analysis of Asymptomatic COVID19 patients using noninvasive mobile tool
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/05/025345
- Lead Sponsor
- Acculi Labs PvtLimited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Subjects must be divided into two major groups:
A) Controlled Group
B) Uncontrolled Group
Control Group:
Proven cases of COVID-19 with or without other health issues like COPD, DM, HTN etc
Uncontrolled Group:
Asymptomatic patients who are not COVID-19 positive, which can be either those who tested negative or normal public.
Exclusion Criteria
1. Terminally ill patients with severe pneumonia
2. Patients with sepsis
3. Patients on ventilator
4. Patients below age of 5 years
5. Patients not willing to give written informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study should prove that Lyfas corona Virus Profile indicator can be used to detect corona virus risk at an asymptomatic stage and can be used to monitor the suspected person with significant statistical correlation in range of patients with different clinical and demogroaphic background.Timepoint: Day 1,3,6 and 10.
- Secondary Outcome Measures
Name Time Method To know the turn around time of the test.Timepoint: Same day